IGFDES
IGF-1 DES
No registered human study names IGF-1 DES as an intervention. ClinicalTrials.gov holds no trial of it, so there is no trial evidence to read — a fact about the public record rather than proof the compound does nothing. No FDA-approved product contains IGF-1 DES. No paper naming IGF-1 DES was published in the last ten years.
Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Counts include only trials whose registered intervention names IGF-1 DES; the registry search is fuzzy, so every match is re-checked. None of this says whether IGF-1 DES works or is safe.
FDA status
Research only
Human studies
0
Furthest phase
—
Papers, 10 yr
0
Readership
—
Tracking since 2026-07-29 · About this data
What has actually been tested in humans
No registered human study
0
Registered human studies
None
No FDA-approved product contains it
No study of IGF-1 DES in humans is registered on ClinicalTrials.gov. That is a fact about the public record, not a statement that the compound does nothing — but it does mean there is no trial evidence to read, and anyone telling you otherwise should be asked for the registration number. The grade is mechanical: it is computed from the registry and the FDA record alone, and it grades how much is known, never whether a compound is good or safe. Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Check the query.
Is anyone studying IGF-1 DES?
No paper naming “IGF-1 DES” in its title or abstract was published between 2017 and 2026, and no registered trial started in that window. That is a fact about the scientific record, not proof the compound does nothing — but it does mean there is no recent literature to read.
Sources: PubMed and ClinicalTrials.gov · collected 2026-08-02 · check the query.
Published research on IGF-1 DES
The 6 papers PubMed ranks most relevant for IGF-1 DES. Listing a paper is not a judgement about it, and none of these is summarised here — follow the link and read what it says.
- The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins
- Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis
- A key functional role for the insulin-like growth factor 1 N-terminal pentapeptide
- Effects of insulin-like growth factors on protein metabolism: why are some molecular variants more potent?
- IGF-I has a dual effect on insulin release from isolated, perifused adult rat islets of Langerhans
- The direct in vitro effect of insulin-like growth factors (IGFs) on normal bovine mammary cell proliferation and production of IGF binding proteins
Collected 2026-08-02from PubMed, phrase-matched on “IGF-1 DES” in title and abstract. Run the same search.
Reading on this compound
All articles →PepRack articles that reference this compound. This is not a news feed — we syndicate nothing and publish no datelines.
Vendor listings are not affiliate links and PepRack earns nothing from them. A listing records a price we observed on a date. It is not a recommendation of a product, dose, or treatment, and PepRack does not verify what any vendor ships.